Marc Y. Donath

31.6k total citations · 8 hit papers
165 papers, 19.5k citations indexed

About

Marc Y. Donath is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Marc Y. Donath has authored 165 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Surgery, 73 papers in Endocrinology, Diabetes and Metabolism and 72 papers in Genetics. Recurrent topics in Marc Y. Donath's work include Diabetes and associated disorders (71 papers), Pancreatic function and diabetes (68 papers) and Adipokines, Inflammation, and Metabolic Diseases (39 papers). Marc Y. Donath is often cited by papers focused on Diabetes and associated disorders (71 papers), Pancreatic function and diabetes (68 papers) and Adipokines, Inflammation, and Metabolic Diseases (39 papers). Marc Y. Donath collaborates with scholars based in Switzerland, United States and Denmark. Marc Y. Donath's co-authors include Steven E. Shoelson, Thomas Mandrup‐Poulsen, Jan A. Ehses, Kathrin Maedler, Marianne Böni‐Schnetzler, Daniel T. Meier, Giatgen A. Spinas, Philippe A. Halban, Mirjam Faulenbach and Helga Ellingsgaard and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Marc Y. Donath

157 papers receiving 19.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type 2 diabetes as an inflammatory disease

2011 2.8k citations Marc Y. Donath et al. profile →
Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

2007 1.4k citations Claus M. Larsen, Mirjam Faulenbach et al. profile →
Inflammation in obesity, diabetes, and related disorders

2022 1.1k citations Daniel T. Meier, Marc Y. Donath et al. profile →
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets

2002 877 citations Kathrin Maedler, Giatgen A. Spinas et al. profile →
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes

2007 613 citations Jan A. Ehses, Helga Ellingsgaard et al. profile →
Targeting inflammation in the treatment of type 2 diabetes: time to start

2014 558 citations Marc Y. Donath profile →
Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation

2017 315 citations Erez Dror, Élise Dalmas et al. Nature Immunology profile →
Targeting innate immune mediators in type 1 and type 2 diabetes

2019 299 citations Marc Y. Donath, Charles A. Dinarello et al. profile →

Peers

Countries citing papers authored by Marc Y. Donath

Since Specialization

Citations

This map shows the geographic impact of Marc Y. Donath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Y. Donath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Y. Donath more than expected).

Fields of papers citing papers by Marc Y. Donath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Y. Donath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Y. Donath. The network helps show where Marc Y. Donath may publish in the future.

Co-authorship network of co-authors of Marc Y. Donath

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Y. Donath. A scholar is included among the top collaborators of Marc Y. Donath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Y. Donath. Marc Y. Donath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study 2025 ·BMJ Open ·Matthias Hepprich, (unknown), Marco Cattaneo, António Ferreira, David Herzig, Lia Bally, Marc Y. Donath	0
2	Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023 2024 ·American Journal of Clinical Nutrition ·M. Furkan Burak, Takara L. Stanley, Elizabeth A. Lawson, (unknown), Lydia Lynch, Alyssa H. Hasty, Ana I. Domingos, Vishwa Deep Dixit, Gökhan S. Hotamışlıgil, Frederick J. Sheedy, Anne E. Dixon, Tina E. Brinkley, Joseph A. Hill, Marc Y. Donath, Steven Grinspoon	5
3	Targeting the NLRP3 inflammasome–IL-1β pathway in type 2 diabetes and obesity 2024 ·Diabetologia ·Daniel T. Meier, (unknown), Marc Y. Donath	26
4	IL-1β promotes adipogenesis by directly targeting adipocyte precursors 2024 ·Nature Communications ·(unknown), (unknown), N Subramanian, Milica Vujičić, (unknown), (unknown), Cheng Zhao, Erez Dror, Emelie Barreby, Niklas K. Björkström, Ingrid Wernstedt Asterholm, Marianne Böni‐Schnetzler, Daniel T. Meier, Marc Y. Donath, Jurga Laurencikiene	16
5	TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial 2024 ·Frontiers in Immunology ·(unknown), (unknown), Courtney Ackeifi, Randy L. Anderson, Roy W. Beck, Marc Y. Donath, Sanjoy Dutta, Joseph A. Hedrick, (unknown), Thomas W. H. Kay, (unknown), (unknown), Jennifer McVean, Thomas Meyer, Jeremy Pettus, Teresa Quattrin, Ruud H J Verstegen, Joshua A Vieth, Esther Latres	10
6	A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models 2023 ·Nature Communications ·(unknown), Fabrice D. Heitz, (unknown), (unknown), Karin Breu, Heather C. Denroche, Julien Thévenet, Melania Osto, Paolo Arosio, Julie Kerr‐Conte, C. Bruce Verchere, François Pattou, Thomas A. Lutz, Marc Y. Donath, Christoph Höck, Roger M. Nitsch, Jan Grimm	13
7	Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass 2023 ·Diabetes Technology & Therapeutics ·(unknown), Katja A. Schönenberger, Natascha Potoczna, Andreas Vogt, Philipp A. Gerber, Jörg Zehetner, Daniel Giachino, Philipp C. Nett, Joanna Gawinecka, (unknown), Daniel G. Fuster, Chiara Dalla Man, Andrea Facchinetti, Andreas Melmer, Christos T. Nakas, Matthias Hepprich, Marc Y. Donath, David Herzig, Lia Bally	7
8	Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing 2022 ·Nature Communications ·Daniel T. Meier, (unknown), (unknown), Shuyang Traub, (unknown), Marc Stawiski, Loïc Sauteur, (unknown), Christelle Le Foll, Catherine Brégère, Raphaël Guzman, Alex Odermatt, Marianne Böni‐Schnetzler, Marc Y. Donath	17
9	Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome 2021 ·Scientific Reports ·Fahim Ebrahimi, Sandrine Urwyler, Matthias Johannes Betz, Emanuel Christ, Philipp Schüetz, Beat Müeller, Marc Y. Donath, Mirjam Christ‐Crain	2
10	Distinct Transcriptional Responses across Tissue-Resident Macrophages to Short-Term and Long-Term Metabolic Challenge 2020 ·Cell Reports ·Urszula Brykczynska, (unknown), (unknown), Erez Dror, Marianne Böni‐Schnetzler, Christoph Hess, Marc Y. Donath, Renato Paro	38
11	Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation breakdown → 2017 ·Nature Immunology ·Erez Dror, Élise Dalmas, Daniel T. Meier, Stephan Wueest, Julien Thévenet, Constanze Thienel, Katharina Timper, Thierry M. Nordmann, Shuyang Traub, Friederike Schulze, Flurin Item, David Vallois, François Pattou, Julie Kerr‐Conte, Vanessa Lavallard, Thierry Berney, Bernard Thorens, Daniel Konrad, Marianne Böni‐Schnetzler, Marc Y. Donath	315
12	Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via Interleukin 6, Produced by α Cells 2016 ·Gastroenterology ·Katharina Timper, Élise Dalmas, Erez Dror, Sabine Rütti, Constanze Thienel, Nadine S. Sauter, Karim Bouzakri, Benoît Bédat, François Pattou, Julie Kerr‐Conte, Marianne Böni‐Schnetzler, Marc Y. Donath	61
13	Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes 2012 ·Diabetes Care ·Claudia Cavelti‐Weder, (unknown), Cornelia Keller, Marc Stahel, M. Kurz–Levin, Hany Zayed, Alan M. Solinger, Thomas Mandrup‐Poulsen, Charles A. Dinarello, Marc Y. Donath	229
14	Cytokine production by islets in health and diabetes: cellular origin, regulation and function 2010 ·Trends in Endocrinology and Metabolism ·Marc Y. Donath, Marianne Böni‐Schnetzler, Helga Ellingsgaard, Philippe A. Halban, Jan A. Ehses	170
15	IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat 2009 ·Proceedings of the National Academy of Sciences ·Jan A. Ehses, Grégory Lacraz, M.H. Giroix, Fabien Schmidlin, Josiane Coulaud, Nadim Kassis, (unknown), Micheline Kergoat, Bernard Portha, F. Homo‐Delarche, Marc Y. Donath	291
16	IL-1 receptor antagonism and muscle gene expression in patients with type 2 diabetes 2009 ·European Cytokine Network ·Lukas Adrian Berchtold, Claus M. Larsen, Allan Vaag, Mirjam Faulenbach, Christopher T. Workman, Mogens Kruhøffer, Marc Y. Donath, Thomas Mandrup‐Poulsen	10
17	Islet Endothelial Activation and Oxidative Stress Gene Expression Is Reduced by IL-1Ra Treatment in the Type 2 Diabetic GK Rat 2009 ·PLoS ONE ·Grégory Lacraz, Marie-Hélène Giroix, Nadim Kassis, Josiane Coulaud, Anne Galinier, Christophe Noll, (unknown), Fabien Schmidlin, Jean‐Louis Paul, Nathalie Janel, Jean-Claude Irminger, Micheline Kergoat, Bernard Portha, Marc Y. Donath, Jan A. Ehses, Françoise Homo‐Delarche	58
18	Insulitis in type 2 diabetes 2008 ·Diabetes Obesity and Metabolism ·Marianne Böni‐Schnetzler, Jan A. Ehses, Mirjam Faulenbach, Marc Y. Donath	50
19	Successful Simultaneous Islet-Kidney Transplantation using a Steroid-free Immunosuppression: Two-Year Follow-up 2004 ·American Journal of Transplantation ·Roger Lehmann, Markus Weber, Peter Berthold, Richard Züllig, Thomas Pfammatter, Wolfgang Moritz, (unknown), Marc Y. Donath, Patrice M. Ambühl, Nicolas Demartines, (unknown), Giatgen A. Spinas	38
20	Expression of Fas but not Fas ligand on fetal pig β cells 2004 ·Xenotransplantation ·Lijun Bai, Kathrin Maedler, Marc Y. Donath, Bernard E. Tuch	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact